Who is the CEO of Noul?

According to the DART company overview, Noul's representative director is 임찬양(단독 대표이사) (name as registered in Korean). The company was founded on 2015-12-02.

Where is Noul listed?

Noul trades on the Korea Exchange KOSDAQ market under the ticker 376930. Its fiscal year ends in December.

Does Noul pay a dividend?

Noul did not pay a cash dividend for fiscal 2025, according to its annual report.

Does Noul have any recent filing signals?

Signals detected automatically from DART filings and quarterly results: Dilution risk (rights offering or CB/BW/EB issue decided in the past 90 days); 4 quarters of losses (operating loss in each of the last four quarters); Private placement (third-party allotment rights offering decided in the past 90 days). 1 more signal is shown on the page. These are factual flags, not investment advice.

Which companies are in the same industry as Noul?

Under the Korean Standard Industrial Classification recorded on DART, Noul is grouped with 11 other listed companies in medical devices. The most covered in Korean news over the past 30 days are LivsMed, Laseroptek and Mediana.

Noul KRX:376930KOSDAQ

노을 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days19

DART filings, 7 days1

Articles tracked29since Sep 11

In Q2 2026, Noul reported revenue of ₩1.0bn, down 28.0% year on year, and an operating loss of ₩4.8bn. Noul (노을) appeared in 19 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Oct 26 with 12 articles. The most common catalyst was stakes & m&a (6). It was most often mentioned alongside ZGOO Holdings, Vuno and Lunit.

Filing signals Private placement Dilution risk 4 quarters of losses Delisting / halt risk Screener

Noul quarterly results consolidated, KRW

Quarter	Revenue	YoY	Operating profit	Net income
Q2 2026	₩1.0bn	-28.0%	−₩4.8bn	−₩4.7bn
Q1 2026	₩322m	-76.9%	−₩4.9bn	−₩4.7bn
Q4 2025 derived	₩1.2bn	+3167.2%	−₩6.7bn	−₩6.3bn
Q3 2025	₩1.1bn	-20.4%	−₩3.9bn	−₩4.0bn
Q2 2025	₩1.4bn	+699.6%	−₩5.0bn	−₩5.3bn
Q1 2025	₩1.4bn	+4717.5%	−₩4.4bn	−₩4.3bn
Q4 2024 derived	₩38m	-94.6%	−₩6.7bn	−₩6.6bn
Q3 2024	₩1.4bn	+166.5%	−₩4.4bn	−₩4.2bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Noul top stories 2 weeks, by number of outlets

1
이틀 연속 상한가 노을, 상폐 위기 벗어나나…주가 1000원 유지가 관건
2 outlets · 3 articlesFirst report Oct 26 18:31 이데일리
2
노을, 최대주주 변경 3자배정 유증에 2거래일 연속 ‘上’
2 outlets · 2 articlesFirst report Oct 26 09:54 조선비즈Stake / acquisition
3
[ET특징주]노을, 최대주주 변경 기대감에 상승세
2 outlets · 2 articlesFirst report Oct 26 13:26 전자신문Stake / acquisition
4
노을, 28억 규모 제3자배정 유상증자 결정
2 outlets · 2 articlesFirst report Oct 23 09:41 뉴시스경제
5
노을, 자궁경부암 AI 진단 유럽 확대…보스니아 공급 계약
1 outlets · 1 articlesFirst report Oct 28 08:47 한국경제Order / supply contract
6
[공시] 노을, 27억5000만원 유상증자···최대주주 변경 예정
1 outlets · 1 articlesFirst report Oct 23 10:45 현대경제신문Stake / acquisition

Latest Noul news Korean headlines

Oct 2808:47

Major노을, 자궁경부암 AI 진단 유럽 확대…보스니아 공급 계약
한국경제Order / supply contract
Oct 2711:19

"하루만 무너져도 위기"…노을, 주가 1000원 턱걸이 지속
EBN
Oct 2709:14

[MK 골든크로스 돌파종목 : 노을(376930) & 웹젠(069080)]
매일경제Webzen
Oct 2618:32
이틀 연속 상한가 노을, 상폐 위기 벗어나나…주가 1000원 유지가 관건
이데일리
2 more on this story · 2 outlets
- 이틀 연속 상한가 노을, 상폐 위기 벗어나나…주가 1000원 유지가 관건이데일리 · Oct 26 18:31
- 이틀 연속 상한가 노을, 상폐 위기 벗어나나…주가 1000원 유지가 관건이데일리증권 · Oct 26 18:31
Oct 2616:28

호재 겹쳐 'AI 의료주' 동반 급등…루닛·노을·뷰노 줄줄이 상한가
한국경제Lunit Vuno
Oct 2613:26
Featured[ET특징주]노을, 최대주주 변경 기대감에 상승세
전자신문Stake / acquisition
1 more on this story · 1 outlets
- 노을, 최대주주 변경 기대감에 이틀 연속 '上'아주경제 · Oct 26 13:31
Oct 2610:57

노을 주가, 10월 26일 장중 상한가 2,170원 29.94% 상승
중앙이코노미뉴스
Oct 2610:20

Featured노을, 지구홀딩스 제3자배정 유증···연이틀 상한가
현대경제신문ZGOO Holdings
Oct 2609:54
Featured노을, 최대주주 변경 3자배정 유증에 2거래일 연속 ‘上’
조선비즈Stake / acquisition
1 more on this story · 1 outlets
- 노을, 최대주주 변경 3자배정 유증에 2거래일 연속 상한가매일경제 · Oct 26 11:06
Oct 2609:51

Featured노을, 최대주주 지구홀딩스 인수 기대.. '상한가'
글로벌이코노믹ZGOO Holdings
Oct 2609:11

Breaking일부 의료AI 관련주 동반 급등…노을·루닛·뷰노 나란히 강세
CBC뉴스Lunit Vuno
Oct 2318:02

노을, 28억원 규모 유상증자 실시
매일경제
Oct 2317:00

Featured노을, 지구홀딩스 최대주주 변경 앞두고 상한가
바이오타임즈Stake / acquisitionZGOO Holdings
Oct 2316:20

유상증자 결정한 노을, 영업현금 유출·매출채권 급증과 맞물린 자금조달 의존성
데일리연합
Oct 2315:59

[공시해부] 노을, 지구홀딩스에 27.5억 유증…최대주주 바뀐다
녹색경제신문ZGOO Holdings
Oct 2310:45

Major[공시] 노을, 27억5000만원 유상증자···최대주주 변경 예정
현대경제신문Stake / acquisition
Oct 2309:41
노을, 28억 규모 제3자배정 유상증자 결정
뉴시스경제
1 more on this story · 1 outlets
- [공시] 노을, 27억5000만원 규모 제3자배정 유상증자글로벌이코노믹 · Oct 23 11:08
Oct 2309:31

Featured노을, 제3자배정 유상증자…'상한가' 직행
뉴스드림
Oct 2308:53

노을, 28억원 유상증자…지구홀딩스 주식회사에 제3자배정
연합뉴스경제ZGOO Holdings
Sep 2215:52

Major노을, ‘마이랩 BCM’ 임상 데이터로 유럽 정조준
한스경제Clinical trial
Sep 2209:03
노을, 유럽 학회서 'miLab BCM' 임상 연구 잇따라 공개
메디파나뉴스
1 more on this story · 1 outlets
- 노을, 유럽 병리·소아 학회서 miLab BCM 임상 성과 공개바이오타임즈 · Sep 22 09:26
Sep 1108:59

노을, 한·아프리카 경제협력회의서 AI 진단 기술 비전 제시
스페셜타임스
Sep 1108:21

노을 내려앉은 도램뜰 공원 주민 발걸음 깨우는 생활체육마당
충청일보

Articles per day 2 weeks

923

1226

227

128

Company profile

CEO: 임찬양(단독 대표이사)
Industry: Medical devices
Founded: 2015-12-02
Fiscal year-end: December
Head office: 경기도 용인시
Website: noul.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Major shareholders latest 5%+ report per holder

Korea 5% stake disclosures

MSEED,INC.10.37%

Each holder's most recent 5% ownership report on DART; names as filed in Korean.

Same industry Medical devices

All in industry

Company	Latest quarter op. profit	Articles 30d
LivsMed	−₩12.2bn	17
Laseroptek	−₩991m	15
Mediana	₩3.0bn	8
i-SENS	₩6.6bn	8
Mezoo	₩875m	7
SD Biosensor	−₩7.3bn	4
PJ Electronics	₩1.8bn	2
Asterasys	₩79m	2

Compare Noul side by side with these companies

Noul DART filings

Oct 2618:19

Trading halt / delisting 기타시장안내 (주가 미달에 따른 상장폐지 우려 관련 안내)
Risk & warnings
Oct 2308:46

Rights offering 주요사항보고서(유상증자결정)
Capital & M&A
Oct 1417:26

Other 기타시장안내 (관리종목 지정사유 추가우려)(시가총액 200억원 미달)
Other
Sep 1017:36

5% ownership report 주식등의대량보유상황보고서(일반)
Ownership reports
Sep 1017:31

Insider ownership report 임원ㆍ주요주주특정증권등소유상황보고서
Ownership reports
Sep 1017:28

Insider ownership report 임원ㆍ주요주주특정증권등소유상황보고서
Ownership reports
Sep 1017:25

Insider ownership report 임원ㆍ주요주주특정증권등소유상황보고서
Ownership reports
Sep 1017:22

Insider ownership report 임원ㆍ주요주주특정증권등소유상황보고서
Ownership reports
Sep 1017:20

Insider ownership report 임원ㆍ주요주주특정증권등소유상황보고서
Ownership reports
Sep 1017:17

Insider ownership report 임원ㆍ주요주주특정증권등소유상황보고서
Ownership reports
Sep 1017:15

Insider ownership report 임원ㆍ주요주주특정증권등소유상황보고서
Ownership reports
Sep 1017:12

Insider ownership report 임원ㆍ주요주주특정증권등소유상황보고서
Ownership reports

Catalysts 2 weeks

Stakes & M&A6
Contracts & orders1

Mentioned alongside 2 weeks

Noul FAQ

Who is the CEO of Noul?: According to the DART company overview, Noul's representative director is 임찬양(단독 대표이사) (name as registered in Korean). The company was founded on 2015-12-02.
Where is Noul listed?: Noul trades on the Korea Exchange KOSDAQ market under the ticker 376930. Its fiscal year ends in December.
What were Noul's latest quarterly results?: In Q2 2026, Noul reported revenue of ₩1.0bn, down 28.0% year on year, and an operating loss of ₩4.8bn. Figures come from reports filed on DART.
Does Noul pay a dividend?: Noul did not pay a cash dividend for fiscal 2025, according to its annual report.
Does Noul have any recent filing signals?: Signals detected automatically from DART filings and quarterly results: Dilution risk (rights offering or CB/BW/EB issue decided in the past 90 days); 4 quarters of losses (operating loss in each of the last four quarters); Private placement (third-party allotment rights offering decided in the past 90 days). 1 more signal is shown on the page. These are factual flags, not investment advice.
Which companies are in the same industry as Noul?: Under the Korean Standard Industrial Classification recorded on DART, Noul is grouped with 11 other listed companies in medical devices. The most covered in Korean news over the past 30 days are LivsMed, Laseroptek and Mediana.